Abnormalities in the regulation of prolactin in patients with chronic renal failure
- PMID: 410821
- DOI: 10.1210/jcem-45-4-658
Abnormalities in the regulation of prolactin in patients with chronic renal failure
Abstract
We have investigated the hypothalamic-hypophyseal regulation of prolactin secretion in patients with chronic renal failure treated with chronic hemodialysis. When compared to control subjects, baseline serum prolactin levels were elevated in the renal failure patients (range 11 to 16 mmicrogram/ml for renal failure patients, 6 to 9 mmicrogram/ml for controls, P less than 0.05). In addition, serum prolactin levels in the renal failure patients failed to suppress significantly following the administration of L-dopa, and did not increase in response to chlorpromazine or thyrotropin releasing hormone. These findings suggest an abnormal regulation of prolactin secretion and appear to be another example of the endocrine dysfunction that occurs in uremic subjects.
Similar articles
-
Abnormalities in the regulation of prolactin in patients on maintenance hemodialysis.Taiwan Yi Xue Hui Za Zhi. 1985 Sep;84(9):1059-70. Taiwan Yi Xue Hui Za Zhi. 1985. PMID: 3937888 No abstract available.
-
Impaired prolactin response to arginine infusion and insulin hypoglycaemia in chronic renal failure.Acta Endocrinol (Copenh). 1983 Apr;102(4):486-91. doi: 10.1530/acta.0.1020486. Acta Endocrinol (Copenh). 1983. PMID: 6405570
-
Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey.J Clin Endocrinol Metab. 1976 Sep;43(3):638-42. doi: 10.1210/jcem-43-3-638. J Clin Endocrinol Metab. 1976. PMID: 821963
-
Influence of naloxone on prolactin secretion in patients with acute and chronic renal failure.Clin Nephrol. 1984 Jan;21(1):47-9. Clin Nephrol. 1984. PMID: 6705273
-
L-DOPA and the control of prolactin secretion.Adv Neurol. 1974;5:447-56. Adv Neurol. 1974. PMID: 4216257 Review. No abstract available.
Cited by
-
Effect of 1,25-dihydroxyvitamin D3 on plasma prolactin in patients with renal failure on regular dialysis treatment.J Endocrinol Invest. 1983 Oct;6(5):359-62. doi: 10.1007/BF03347616. J Endocrinol Invest. 1983. PMID: 6689332
-
Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.J Endocrinol Invest. 1991 May;14(5):383-9. doi: 10.1007/BF03349087. J Endocrinol Invest. 1991. PMID: 1908493 Clinical Trial.
-
A prospective analysis of testicular androgenic function in recipients of a renal allograft.Int Urol Nephrol. 2008;40(2):397-403. doi: 10.1007/s11255-007-9277-8. Int Urol Nephrol. 2008. PMID: 18392945
-
Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKD.Heliyon. 2024 Jun 11;10(12):e32828. doi: 10.1016/j.heliyon.2024.e32828. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 38975221 Free PMC article.
-
Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.J Endocrinol Invest. 1982 Sep-Oct;5(5):281-6. doi: 10.1007/BF03350515. J Endocrinol Invest. 1982. PMID: 6818270
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources